Walgreens Boots Is Exploring a Potential Take-Private Deal

By Bloomberg
November 6, 2019 Updated: November 6, 2019

Walgreens Boots Alliance Inc., led by Chief Executive Officer Stefano Pessina, has been reviewing a potential deal to take the company private in what could become the largest leveraged buyout in history, people familiar with the matter said.
The company has recently held informal talks with private equity firms including KKR & Co., the people said, asking not to be identified because the information is private. Pessina is Walgreens Boots’s largest shareholder with a stake of about 16%, according to data compiled by Bloomberg.

Deerfield, Illinois-based Walgreens Boots has a market value of about $55 billion and $16.8 billion of debt. At that size, a take-private of the company would top the largest leveraged buyout in history: the 2007 sale of utility TXU Corp. to KKR & Co. and TPG, which was worth about $45 billion including debt, according to data compiled by Bloomberg.

Some of the buyout firms have so far shown reluctance to participate in a deal, the people said. It’s unclear how feasible the transaction would be, and the company could decide against pursuing the idea, the people said.

Representatives for Walgreens Boots and KKR declined to comment.

Walgreens Boots rose 3.1% to $61.52 at 3:38 p.m. in New York trading. Its bonds dropped the most ever.

Under Pressure

A buyout would give Walgreens Boots time to adapt to a fast-changing retail landscape, free from the quarter-by-quarter demands of public shareholders.

The company is under immense pressure from online competitors including Amazon.com Inc., which have chipped away at front-of-the-store sales of household and beauty items. While top rival CVS Health Corp. has grown into a vertically integrated health-care giant, Walgreens Boots has doubled down on retail, announcing pilot partnerships with retailers including grocer Kroger Co.

It has also announced an ambitious $1.8 billion in annual cost cuts and plans to shutter its in-store health clinics.

This wouldn’t be Pessina’s first ambitious private equity deal.

The native of Italy previously ran Alliance Boots, which he had acquired with KKR in 2007. The transaction came at the height of the buyout boom and underscored the challenges of financing jumbo take-privates, as banks struggled at the time to find buyers for the loans to pay for that deal.

Pessina, 78, took his current role after Walgreen Co. acquired the part of Alliance Boots that it didn’t already own for about $15.3 billion in 2014.

Walgreens Boots is the largest retail pharmacy in the U.S. and Europe, with more than 18,750 stores in 11 countries, according to its most recent annual report. Its wholesale arm has more than 400 distribution centers that deliver to more than 240,000 pharmacies, doctors’ health centers, and hospitals annually. It operates Walgreens and Duane Reade stores in the U.S. and Boots stores in Europe and Asia.

The company had sought to buy rival Rite Aid Corp. In 2017, the companies scrapped the merger amid regulatory concerns that it would hurt competition in the U.S. drugstore market. Walgreens Boots instead bought roughly 2,000 stores from Rite Aid.